Category: <span>Mesothelioma treatment</span>

Category: Mesothelioma treatment

Anetumab ravtansine, BAY 94-9343, clinical trials for mesothelioma, David Sugarbaker, immunotherapy mesothelioma clinical trial, Mesothelioma News, Mesothelioma treatment, stage 4 mesothelioma, stage IV mesothelioma

Sugarbaker: Mesothelioma Clinical Trial May Be ‘Home Run’

 

Thoracic surgeon and mesothelioma visionary Dr. David Sugarbaker already is thinking two steps ahead, anticipating the optimal utilization of this latest clinical trial drug combination. That’s what leaders do. A phase II, multicenter clinical trial involving the antibody-drug conjugate anetumab ravtansine (BAY 94-9343) for patients with stage IV pleural mesothelioma opened recently with considerable expectations,…

The post Sugarbaker: Mesothelioma Clinical Trial May Be ‘Home Run’ appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Anetumab ravtansine, BAY 94-9343, clinical trials for mesothelioma, David Sugarbaker, immunotherapy mesothelioma clinical trial, Mesothelioma News, Mesothelioma treatment, stage 4 mesothelioma, stage IV mesothelioma

Sugarbaker: Mesothelioma Clinical Trial May Be ‘Home Run’

 

Thoracic surgeon and mesothelioma visionary Dr. David Sugarbaker already is thinking two steps ahead, anticipating the optimal utilization of this latest clinical trial drug combination. That’s what leaders do. A phase II, multicenter clinical trial involving the antibody-drug conjugate anetumab ravtansine (BAY 94-9343) for patients with stage IV pleural mesothelioma opened recently with considerable expectations,…

The post Sugarbaker: Mesothelioma Clinical Trial May Be ‘Home Run’ appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

antitumor, extending mesothelioma survival, malaria drug, malignant pleural mesothelioma, mesothelioma clinical trial, Mesothelioma News, Mesothelioma treatment, onconase, onconase clinical trial, tongji university

Study: Onconase, Malaria Drug Extends Mesothelioma Survival

 

A new treatment combining two existing drugs — one derived from frog eggs and another given to combat malaria — may be the key to extending mesothelioma survival. Scientists at Tongji University in Shanghai, China, discovered that mixing Onconase, an enzyme present in early-stage leopard frog embryos, with antimalarial drug dihydroartemisinin (DHA) synergistically suppressed growth…

The post Study: Onconase, Malaria Drug Extends Mesothelioma Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, asbestos lung cancer, KRAS lung cancer, KRAS mutation, lung cancer study, mesothelioma clinical trial, Mesothelioma News, Mesothelioma Research, Mesothelioma treatment

New Lung Cancer Study May Improve Mesothelioma Therapy

 

New insight into the gene responsible for the most aggressive subtype of non-small cell lung cancer (NSCLC) could bring hope for mesothelioma patients. Researchers from UT Southwestern Medical Center identified a new way to target lung cancer through the Kirsten rat sarcoma viral oncogene homolog, also known as the KRAS gene. Tumors that carry a…

The post New Lung Cancer Study May Improve Mesothelioma Therapy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

malignant pleural mesothelioma treatment, mesothelioma cancer, mesothelioma chemotherapy, mesothelioma clinical trial, Mesothelioma News, Mesothelioma treatment, nintedanib, Ofev, rama balaraman

Researchers Test Nintedanib in Mesothelioma Clinical Trial

 

Medical oncologist Dr. Rama Balaraman isn’t expecting any miracles from the pleural mesothelioma clinical trial involving nintedanib, the small-molecule enzyme inhibitor. She is expecting progress. Balaraman, at Florida Cancer Affiliates in Ocala, is participating in an international, multicenter trial that will expand the use of nintedanib within the U.S., giving patients another weapon in this…

The post Researchers Test Nintedanib in Mesothelioma Clinical Trial appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma News, Mesothelioma treatment, sea squirt cancer treatment, sea squirt trabectedin toxin, sea toxin for cancer, trabectedin, trabectedin for mesothelioma

New Mesothelioma Drug Discovered in Sea Squirt Toxin

 

A unique drug derived from the Caribbean sea squirt shows impressive effectiveness in stopping the growth of mesothelioma tumor cells. Researchers at the Medical University of Vienna in Austria discovered that trabectedin, a toxin the coral-like animal uses against predators, might soon be applied in the treatment of mesothelioma. “It has looked very promising to…

The post New Mesothelioma Drug Discovered in Sea Squirt Toxin appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

best cancer centers, best cancer hospitals, best hospitals for cancer, best hospitals rankings, best mesothelioma cancer centers, md anderson cancer center, Mesothelioma News, Mesothelioma treatment, moffitt cancer center, us news and world report best hospitals

Many Mesothelioma Centers Top List of Best Cancer Hospitals

 

The University of Texas MD Anderson Cancer Center retained its standing as the top cancer care hospital in the nation for the second consecutive year, according to U.S. News & World Report. The publication’s 2016-17 Best Hospitals for Cancer graded cancer centers from 0-100 on a variety of categories such as reputation with specialists, volume…

The post Many Mesothelioma Centers Top List of Best Cancer Hospitals appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

cancer treatment, CBS, Costs of Cancer, Food and Drug Administration (FDA), Medicare, mesothelioma cancer, Mesothelioma News, Mesothelioma treatment, National Institutes of Health (NIH)

Mesothelioma and Asbestos Claims Hit Hartford Financial Company Hard

 

Hartford Connecticut Financial Company’s profits dropped drastically in Q2 due to an asbestos and mesothelioma cases in its property and casualty business.

best surgery for mesothelioma, cancer surgery, Mesothelioma News, mesothelioma surgery, Mesothelioma treatment, older mesothelioma patients, seer mesothelioma results

New Study: Mesothelioma Surgery Still Benefits Older Patients

 

Older patients with pleural mesothelioma can double their chances of extending their survival rates by undergoing aggressive, potentially curative surgery, according to a recent national database analysis. Age also should not be a deterrent to surgery, refuting the lingering myth that many mesothelioma patients are too old to benefit from these procedures. “More and more,…

The post New Study: Mesothelioma Surgery Still Benefits Older Patients appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

best surgery for mesothelioma, cancer surgery, Mesothelioma News, mesothelioma surgery, Mesothelioma treatment, older mesothelioma patients, seer mesothelioma results

New Study: Mesothelioma Surgery Still Benefits Older Patients

 

Older patients with pleural mesothelioma can double their chances of extending their survival rates by undergoing aggressive, potentially curative surgery, according to a recent national database analysis. Age also should not be a deterrent to surgery, refuting the lingering myth that many mesothelioma patients are too old to benefit from these procedures. “More and more,…

The post New Study: Mesothelioma Surgery Still Benefits Older Patients appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

best surgery for mesothelioma, cancer surgery, Mesothelioma News, mesothelioma surgery, Mesothelioma treatment, older mesothelioma patients, seer mesothelioma results

New Study: Mesothelioma Surgery Still Benefits Older Patients

 

Older patients with pleural mesothelioma can double their chances of extending their survival rates by undergoing aggressive, potentially curative surgery, according to a recent national database analysis. Age also should not be a deterrent to surgery, refuting the lingering myth that many mesothelioma patients are too old to benefit from these procedures. “More and more,…

The post New Study: Mesothelioma Surgery Still Benefits Older Patients appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

cancer chemotherapy, chemotherapy drugs, chemotherapy drugs for mesothelioma, chemotherapy for mesothelioma, Mesothelioma News, Mesothelioma treatment, moffitt cancer center, new chemotherapy drug

New Mesothelioma Treatment Guidelines May Extend Survival

 

The National Comprehensive Cancer Network (NCCN) has changed its first-line treatment recommendation for unresectable pleural mesothelioma, believing it will extend patient survival significantly. The NCCN advisory panel recently added the monoclonal antibody bevacizumab to the long-standing chemotherapy combination of pemetrexed and cisplatin. Bevacizumab, also known by brand name Avastin, inhibits the formation of new blood…

The post New Mesothelioma Treatment Guidelines May Extend Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

cancer chemotherapy, chemotherapy drugs, chemotherapy drugs for mesothelioma, chemotherapy for mesothelioma, Mesothelioma News, Mesothelioma treatment, moffitt cancer center, new chemotherapy drug

New Mesothelioma Treatment Guidelines May Extend Survival

 

The National Comprehensive Cancer Network (NCCN) has changed its first-line treatment recommendation for unresectable pleural mesothelioma, believing it will extend patient survival significantly. The NCCN advisory panel recently added the monoclonal antibody bevacizumab to the long-standing chemotherapy combination of pemetrexed and cisplatin. Bevacizumab, also known by brand name Avastin, inhibits the formation of new blood…

The post New Mesothelioma Treatment Guidelines May Extend Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

cancer chemotherapy, chemotherapy drugs, chemotherapy drugs for mesothelioma, chemotherapy for mesothelioma, Mesothelioma News, Mesothelioma treatment, moffitt cancer center, new chemotherapy drug

New Mesothelioma Treatment Guidelines May Extend Survival

 

The National Comprehensive Cancer Network (NCCN) has changed its first-line treatment recommendation for unresectable pleural mesothelioma, believing it will extend patient survival significantly. The NCCN advisory panel recently added the monoclonal antibody bevacizumab to the long-standing chemotherapy combination of pemetrexed and cisplatin. Bevacizumab, also known by brand name Avastin, inhibits the formation of new blood…

The post New Mesothelioma Treatment Guidelines May Extend Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

cancer treatments, IMPRINT for mesothelioma, lung cancer treatments, Mesothelioma News, Mesothelioma treatment, pleural mesothelioma, radiation for mesothelioma, radiation therapy

IMPRINT Mesothelioma Treatment Boosts Radiation Therapy

 

Doctors confirmed a novel radiation procedure can be combined safely and effectively with aggressive lung-sparing surgery to improve survival time and quality of life for patients with mesothelioma. After a decade of refinement, a small number of mesothelioma specialty centers now are using intensity-modulated pleural radiation therapy (IMPRINT) as part of the recent advancements in…

The post IMPRINT Mesothelioma Treatment Boosts Radiation Therapy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.